© 2011, Crown Copyright.
Included under terms of UK Non-commercial Government License.
Bookshelf ID: NBK109542
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Wang D, Bayliss S, Meads C. Palivizumab for Immunoprophylaxis of Respiratory Syncytial Virus (RSV) Bronchiolitis in High-Risk Infants and Young Children: Systematic Review and Additional Economic Modelling of Subgroup Analyses. Southampton (UK): NIHR Journals Library; 2011 Jan. (Health Technology Assessment, No. 15.5.)
Palivizumab for Immunoprophylaxis of Respiratory Syncytial Virus (RSV) Bronchiolitis in High-Risk Infants and Young Children: Systematic Review and Additional Economic Modelling of Subgroup Analyses.
Show details- AGE
birth age
- CEAC
cost-effectiveness acceptability curve
- CI
confidence interval
- CLD
chronic lung disease
- CHD
congenital heart disease
- GA
gestational age
- HRQoL
health-related quality of life
- HTA
Health Technology Assessment
- HUI
Health Utilities Index
- ICER
incremental cost-effectiveness ratio
- MB
multiple birth
- NICE
National Institute for Health and Clinical Excellence
- OC
overcrowding
- OR
odds ratio
- PE
parental education
- PSA
probabilistic sensitivity analysis
- QALY
quality-adjusted life-year
- RCT
randomised controlled trial
- RR
rate ratio
- RSV
respiratory syncytial virus
- SAS
siblings at school
- SE
smoking exposure
All abbreviations that have been used in this report are listed here unless the abbreviation is well known (e.g. NHS), or it has been used only once, or it is a non-standard abbreviation used only in figures/tables/appendices, in which case the abbreviation is defined in the figure legend or in the notes at the end of the table.
- List of abbreviations - Palivizumab for Immunoprophylaxis of Respiratory Syncyti...List of abbreviations - Palivizumab for Immunoprophylaxis of Respiratory Syncytial Virus (RSV) Bronchiolitis in High-Risk Infants and Young Children: Systematic Review and Additional Economic Modelling of Subgroup Analyses
- Qualitative research study profiles - OPTIMA prelim: a randomised feasibility st...Qualitative research study profiles - OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer
- Ongoing trials - Clinical effectiveness and cost-effectiveness of use of therape...Ongoing trials - Clinical effectiveness and cost-effectiveness of use of therapeutic monitoring of tumour necrosis factor alpha (TNF-α) inhibitors [LISA-TRACKER® enzyme-linked immunosorbent assay (ELISA) kits, TNF-α-Blocker ELISA kits and Promonitor® ELISA kits] versus standard care in patients with Crohn’s disease: systematic reviews and economic modelling
- Plain English summary - Different temperature thresholds for antipyretic interve...Plain English summary - Different temperature thresholds for antipyretic intervention in critically ill children with fever due to infection: the FEVER feasibility RCT
- References - OPTIMA prelim: a randomised feasibility study of personalised care ...References - OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer
Your browsing activity is empty.
Activity recording is turned off.
See more...